Intensified

Hydron Energy Receives Funding from the Clean Resource Innovation Network (CRIN) to Commercialize the INTRUPTor™ Technology, a Low Cost and Novel Waste-to-Fuel System.

Retrieved on: 
Wednesday, December 6, 2023
Carbon, Biomass, Chemistry, Hydron, Intensified, Natural gas, RNG, CRIN, Innovation system, Renewable energy

The grant from CRIN will provide funding to help accelerate commercialization and scale up for the INTRUPTor™ system.

Key Points: 
  • The grant from CRIN will provide funding to help accelerate commercialization and scale up for the INTRUPTor™ system.
  • Hydron Energy is scaling up core components of the INTRUPTor™ by orders of magnitude.
  • "We looked at how nature removes carbon dioxide from our body as we exhale, then we created an industrial version of the natural process.
  • Hydron Energy's Intensified Regenerative Upgrading Platform Technology (INTRUPTor™) system is a disruptive solution that converts raw gases into clean refined fuel.

Hydron Energy Receives Funding from the Natural Gas Innovation Fund (NGIF) to Support INTRUPTor™ Technology Scale Up for its Waste-to-Fuel Program

Retrieved on: 
Thursday, November 16, 2023
Hydron, Intensified, Aircraft, Natural gas, RNG, Renewable natural gas, Innovation system

Hydron has developed a first-of-a-kind gas upgrader, the INTRUPTor™, to produce low cost renewable fuels such as renewable natural gas (RNG) from biogas, as well as clean hydrogen production from syngas.

Key Points: 
  • Hydron has developed a first-of-a-kind gas upgrader, the INTRUPTor™, to produce low cost renewable fuels such as renewable natural gas (RNG) from biogas, as well as clean hydrogen production from syngas.
  • "The high cost of biogas upgrading is an obstacle on the renewable natural gas development path.
  • With the grant from NGIF Hydron will be able to scale up this disruptive technology by orders of magnitude to service the conventional biogas upgrading market.
  • Hydron Energy is initially focused on providing an affordable and scalable solution to produce renewable natural gas (RNG) from anaerobically digested biofuels.

Hydron Energy and Modern Niagara Announce Strategic Partnership and Investment to Accelerate First Product Launch to Market

Retrieved on: 
Monday, December 12, 2022
EnergySolutions, Innovation, CICE, Plant, GHG, Transport, RNG, Partnership, Sale, Natural gas, Module, Multimedia, Intensified, Oil, Renewable energy, Hydron

This partnership and funding will accelerate Hydron's INTRUPTor commercialization strategy and support manufacturing Hydron's proprietary components in Canada.

Key Points: 
  • This partnership and funding will accelerate Hydron's INTRUPTor commercialization strategy and support manufacturing Hydron's proprietary components in Canada.
  • "Modern Niagara brings deep experience in high volume production and value engineering, as well as access to significant commercial relationships," said Hydron Energy President and CEO Soheil Khiavi.
  • Modern Niagara's equity investment in Hydron will be directed toward product commercialization and manufacturing development.
  • Hydron Energy is the cleaner fuel company helping hard-to-decarbonize sectors, such as transportation and industry, meet future energy demands and net-zero goals.

Pharmacovigilance Market Research Report 2022: Rising Incidence of ADR and Drug Toxicity Fueling Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 28, 2022
Health, Other Science, General Health, Clinical Trials, Research, Science, Pharmaceutical, Health care provider, GBP, USD, JPY, Contract, Research, Market share analysis, Mining, AUD, Pharmacovigilance, Acquisition, Growth, CAD, Method, CAGR, Customer support, Hospital, Academy, Government, Clinical trial, Business Growth Fund, CHF, Decision-making, Strategic management, Use, Intensified, Value, Pharma, Cryptocurrency, Pharmaceutical industry, Retail, EUR

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF.

Key Points: 
  • The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF.
  • This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the market was studied across Contract Outsourcing and In-house.
  • Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
  • Based on Method, the market was studied across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.

The United States Pharmacovigilance Market Size is Expected to Reach USD 3,109.03 Million by 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 24, 2022
Health, Science, Pharmaceutical, Research, Clinical Trials, CAD, Contract, Hospital, Use, R, Certification, Customer support, Compound annual growth rate, EUR, Health care provider, Investment, Business Growth Fund, Academy, State, Strategic management, Pharmacovigilance, USD, Decision-making, COVID-19, Research, Consumer, Clinical trial, JPY, Pharma, Government, Technology, Intensified, Mining, Market share analysis, AUD, GBP, CAGR, CHF, Growth, Acquisition, Value, Pharmaceutical industry, Cryptocurrency, Fine chemical, Retail, Method

The United States Pharmacovigilance Market size was estimated at USD 1,373.24 million in 2021 and expected to reach USD 1,554.08 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.58% to reach USD 3,109.03 million by 2027.

Key Points: 
  • The United States Pharmacovigilance Market size was estimated at USD 1,373.24 million in 2021 and expected to reach USD 1,554.08 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.58% to reach USD 3,109.03 million by 2027.
  • What is the market size and forecast of the United States Pharmacovigilance Market?
  • What is the market share of the leading vendors in the United States Pharmacovigilance Market?
  • What modes and strategic moves are considered suitable for entering the United States Pharmacovigilance Market?

Global Pharmacovigilance Market Forecast Report to 2026 - Rise in Pharmacovigilance Applications in Spontaneous Reporting and Electronic Health Record (EHR) Mining - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 17, 2022
Health, Pharmaceutical, Contract, Hospital, R, Certification, Compound annual growth rate, Investment, Health care provider, News, Collaborative partnership, Academy, Pharmacovigilance, USD, Research, Method, Clinical trial, Mergers and acquisitions, Pharma, Government, Intensified, Mining, Market share analysis, CAGR, Acquisition, Growth, Fine chemical, Pharmaceutical industry, Retail

This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the Pharmacovigilance to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the market was studied across Contract Outsourcing and In-house.
  • Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
  • Based on Method, the market was studied across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.
  • Based on End User, the market was studied across Academic & Research Institutes, Government Agencies, Health Insurance Companies, Hospitals & Care Providers, and Pharma & Biotech Companies.

Pharmacovigilance & Drug Safety Software Market Research Report 2022 - Global Forecast to 2027 - Cumulative Impact of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 10, 2022
Health, Pharmaceutical, Cloud, Business process, Industry, Clinical trial, Collaborative partnership, USD, Pharmacovigilance, Mergers and acquisitions, Research, Weakness, Consumer, Distribution, Mining, News, Acquisition, Market share analysis, Investment, Intensified, COVID-19, Method, Growth, Software, CAGR, Gaps, Comparison of help desk issue tracking software, Contract, Pharmaceutical industry, Retail, Risk management, Region

The "Pharmacovigilance & Drug Safety Software Market Research Report by Product, by Clinical Trial, by Method, by Distribution, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmacovigilance & Drug Safety Software Market Research Report by Product, by Clinical Trial, by Method, by Distribution, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward.
  • Based on Product, the market was studied across Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software, and Issue Tracking Software.
  • Based on End User, the market was studied across Business Process Outsourcing Firms, Contract Research Organizations, Pharma & Biotech Companies, and Pharmacovigilance Service Providers.